Urine samples from 26 cigarette smokers on a restricted diet were collected in the late afternoon. Urine extracts on XAD-2 resin were tested for mutagenicity in the microsuspension assay using Salmonella typhimurium strain TA98 in the presence of metabolizing and deconjugating enzymes. Levels of urinary nicotine plus metabolites and cotinine were determined. Eighteen samples were clearly mutagenic, i.e. capable of doubling the number of spontaneous revertants at one of the assayed doses of urine. Urinary mutagenic activity ranged from 193 to 8462 net revertants/ mmol of creatinine, while urinary nicotine plus metabolites and cotinine levels varied from 0.007 to 1366 and from 0.011 to 0.297 mg/mmol creatinine. Urine samples with nicotine metabolite levels of <033, 033-<0.66 and >0.66 mg/mmol creatinine had mean values ± SD of mutagenic activity of 490 ± 222 (n = 10), 964 ± 560 (n = 9) and 2692 ± 2807 (n = 7) revertants/mmol of creatinine, respectively, the statistical comparison between the groups being positive (Mann-Whitney tZ-test, P < 0.05). The mutagenic activity of urine samples from smokers correlated well with urinary nicotine plus metabolite levels (r = 0.658, P < 0.01). A less close correlation was found between urinary mutagenic activity and other indicators of tobacco smoke exposure, such as urinary cotinine (r = 0.504, P < 0.05), number of cigarettes smoked during the day of urine collection (r = 0.399, P < 0.05) and machine smokingderived nicotine deliveries of the total number of cigarettes smoked (number of cigarettes multiplied by the nicotine content of each cigarette, as indicated by the manufacturer; r = 0.439, P < 0.05). These results suggest that the mutagenic activity of smokers' urine may be predicted by the urinary level of nicotine plus metabolites. The low degree of reliability of many presumptive indicators of exposure to tobacco smoke and the different urinary excretion kinetics of tobacco smoke mutagens with respect to cotinine (a frequently used biomarker for monitoring exposure to tobacco smoke) are both emphasized.
Introduction
Increases in urinary mutagenicity have been observed in workers exposed to specific genotoxic compounds and complex mixtures (Everson, 1986) . Nevertheless, some lifestyle factors such as dietary habits (Baker et al, 1982; Sasson et al, 1985; Sousa et al, 1985; Doolittle et al, 1989) , together with active (IARC, 1986) and passive smoking (Bos et al., 1983) , have also been reported to increase urinary mutagen levels. It is therefore important to check these confounding exposures © UK Environmental Mutagen Society/Oxford University Press 1996 carefully by means of questionnaires or biomarkers when urinary mutagenicity is used in biological monitoring programs.
As regards smoking status, biomarkers allow more accurate measurement of the degree of exposure to cigarette smoke than questionnaires, because they take into account all the variables playing important roles in the absorption of smoke constituents, such as frequency and volume of puffs, inhalation profile, smoke retention time and individual metabolic variations. Several studies have indicated that urinary cotinine, a nicotine metabolite, is a good biomarker of individual exposure to tobacco smoke (Pojer et al., 1984) . The literature reports conflicting results on the correlation between urinary mutagens and number of cigarettes smoked, urinary cotinine levels or other objective parameters of exposure to tobacco smoke. Several researchers have observed an increase in urinary mutagenicity in smokers, with increased levels of tobacco smoke exposure with respect to non-smokers, but in many cases no clear linear correlation between urinary mutagenic activity and tobacco smoke exposure indicators has been found either in active (Falck, 1982; Recio et al., 1982; Jaffe et al., 1983; Sasson et al., 1985; Sorsa et al, 1985) or in passive smokers (Mohtashamipur et al., 1987) . Other studies generally carried out on a higher number of subjects have shown the close correlation between urinary concentrations of nicotine and cotinine (Bartsch et al., 1990; Rahn et al., 1991) or between the number of cigarettes smoked per day (Mohtashamipur et al., 1985; Tuomisto et al, 1986; Kawano et al, 1987) or blood carboxyhemoglobin levels (Marshall et al, 1983) and mutagenic activity in urine. The present study evaluated the mutagenicity and contents of nicotine plus metabolites and cotinine in cigarette smokers' urine. The relationships between these biological markers of human exposure to tobacco smoke with external exposure indicators such as number of cigarettes smoked and machine smoking-derived deliveries of nicotine and tar were also studied.
Materials and methods

Samples
Spot urine samples from 26 smokers were collected in the late afternoon between 5.00 and 7.00 p.m. in polyethylene containers and stored at -20°C in the dark. Over-diluted urine samples (< 0.5 g creaunine/1) were discarded and collection repeated.
Information on smoking habits included number of cigarettes smoked on the day of urine collection from the moment of awakening, with or without inhalation and brand name. Additional information on age, sex, occupation, hobbies, medication and dietary intake in the 2 days before sampling was obtained by means of questionnaires. All subjects included in the study avoided diets known to cause increased urinary mutagenicity (e.g. eating fried, grilled or barbecued meat).
Urinary mutagenicity assay
After being thawed and filtered, urine samples were eluted in glass columns (I.5X 10 cm) packed with washed XAD-2 resin (4 g/100 ml urine) (Yamasaki and Ames, 1977) . Extracts were taken up in acetone, dried under a N 2 stream and resuspended in dimethyl sulfoxide (DMSO), to concentrate the urine 1000 times (1 ml unne/1 \i\ DMSO).
The mutagenicity of the urinary extracts was evaluated using the microsuspension preincubation assay (Kado et al., 1983) , consisting of a modification M. Granella el al. to Ames' basic procedure (Maron and Ames, 1983) . Five microliters of urinary extract, 100 |il of 10% S9 mix containing (J-glucuronidase (200 U/ plate) and bacteria (obtained after tenfold concentration of a overnight culture of strain TA98 of Salmonella typhimurium) were incubated at 37°C for 90 min in a bath under shaking. The 9000 g supernatant, containing microsomal fractions obtained from male Sprague-Dawley rat liver induced with Aroclor 1254 (mixture of polychlorinated biphenyls), was used in the S9 mix. Several concentrations of unne extracts were tested in duplicate at a minimum of four doses, ranging from 0.25 to 5 ml. The mean values of two replications are reported here. Benzo[a]pyrene (1 ng/plate) was used as positive control. Mean spontaneous revertants in all experiments (n = 12) were 28.7 ± 5.6. Sample mutagenic activity, expressed as revertants/mmol of creatinine, was the slope of the linear portion of the dose-response curve calculated by the linear regression method on at least five doses (DMSO spontaneous revertants providing the 0 concentration). The minimum amount of urine capable of doubling the number of revertants with respect to spontaneous ones was called the minimum mutagenic dose. Doses producing a clear toxic effect, as revealed by the lack of background bacterial growth on the plates, were not considered.
Determination of nicotine plus metabolites and cotinine, and subjective evaluation of tobacco smoke intake
Urine concentration of nicotine plus metabolites was determined colorimetrically by the diethyl thiobarbitunc acid (DETB) extraction method (Peach et al., 1985) , based on the Koenig reaction. DETB, used as a condensing agent, gives a pink product which can easily be extracted in ethyl acetate. Optical density was measured spectrophotometrically at a wavelength of 532 nm. Metabolite concentrations were calculated according to the calibration curve of cotinine in an aqueous solution.
Urinary levels of cotinine were analysed by gas chromatography with a UV detector (Godin et al, 1985) after sample extraction with chloroform, according to the sample procedure preparation suggested by Godin and Hellier (1989) . The calibration curve was made by adding known quantities of cotinine in methanol to the urine of a non-smoker; pyndine was used as internal standard.
Tar and nicotine intake levels were estimated from the number of cigarettes smoked multiplied by the tar and nicotine contents of each cigarette, as reported by the manufacturer on the cigarette pack. No subject smoked cigarettes made from black (air-cured) tobacco.
Correction of measured values with respect to dilution/concentration of urine samples
The mutagenic potency and concentrations of nicotine plus metabolites and cotinine in each sample were expressed per mmol of urinary creatinine, determined on the Boehringer-Mannheim colorimetric test based on the reaction of creatinine with picrate in alkaline medium.
Results
Smokers' characteristics and mutagenic activity, and the contents of nicotine plus metabolites and cotinine in smokers' urine samples are shown in Table I .
On the sampling day, before urine collection, subjects had smoked between 1 and 25 cigarettes. The amounts of machine smoking-derived deliveries of nicotine ranged from 0.1 to 20 mg and tar varied from 0.9 to 225 mg. Eighteen samples showed clear mutagenic activity (i.e. one of the assayed doses was capable of doubling the number of spontaneous revertants); eight did not. The highest values of mutagenic activity (up to -8500 revertants/mmol creatinine) were mainly detected in urine from heavy smokers, although not always (exceptions were samples 6 and 9). The same was observed for the lowest values, which were more frequent in light smokers, although with some significant exceptions (samples 15 and 17). Two light smokers (samples 7 and 9) had urine mutagenic activity comparable to that of heavy smokers.
Urinary nicotine plus metabolite levels ranged from 0.007 to 1.366 mg/mmol of creatinine. The lowest value was measured in the urine of a light smoker who did not inhale. Except for this sample, together with that of subjects smoking one cigarette per day (samples 1 and 8), the cotinine contents in urine samples from smokers were always lower than those of nicotine plus metabolites, and ranged from 0.011 to 0.297 mg/ mmol creatinine.
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Smokers' urinary mutagenic activity is reported in Table II , in relation to various levels of the indicators of tobacco smoke exposure, both estimated and on the basis of urinary biomarkers. All parameters were capable of identifying subjects with the greatest exposure to mutagens due to tobacco smoking. However, many errors in classification arose, i.e. subjects with mutagenic urine with low levels of exposure and vice versa. Comparison of mutagenic activity in the most heavily exposed groups with the correspondingly least exposed groups was statistically significant (Mann-Whitney t/-test, P < 0.01 or P < 0.05), with the sole exception of the group with the highest urinary excretion of cotinine. Almost all the urine samples with contents of nicotine plus metabolites 5*0.33 mg/mmol creatinine were positive on the mutagenesis test and had mutagenic activity which was significantly higher than that of the least exposed group (mean values for the two groups were respectively 2692 ± 2807 and 964 ± 560, as opposed to 490 ± 222; Mann-Whitney U-tesl, P < 0.05). Urinary mutagenic activity was better correlated to urinary levels of nicotine plus metabolites (r = 0.658, F = 18.37, P < 0.01) than of cotinine (r = 0.504, F = 7.50, P < 0.05) ( Table III) . Lower correlations were also found between urinary mutagenic activity and the number of cigarettes smoked (r = 0.399, F = 4.45, P < 0.05) and machine smoking-derived nicotine deliveries (r = 0.439, F = 5.73, P < 0.05), but not using the machine smokingderived deliveries of tar as an indicator of tobacco smoke exposure.
The values of urinary nicotine plus metabolites and cotinine were closely correlated both with the number of cigarettes smoked and with machine smoking-derived deliveries of nicotine. The values of urinary nicotine plus metabolites were correlated better with the number of cigarettes smoked on the sampling day (r = 0.704, F = 23.6, P < 0.01).
Discussion
The correlations between mutagenic activity, nicotine plus metabolites, cotinine in cigarette smokers' urine and other subjective estimates of tobacco smoke exposure were studied.
Eight samples from subjects smoking 3-12 cigarettes in the sampling day were not mutagenic in the microsuspension assay. Other authors found mutagenic-negative samples in the plate incorporation assay in urinary extracts on XAD-2 resins from smokers consuming four or fewer cigarettes per day (Mohtashamipur et al., 1985) , but increased sensitivity was reported when using the microsuspension assay, which is able to detect increased urinary mutagenicity in subjects smoking only a few cigarettes per day (Kado et al, 1985) . The fact that we found no mutagenic activity in a few urine samples from subjects who smoked a considerable number of cigarettes and had high levels of nicotine plus metabolites in their urine may be explained by the capacity of some urinary extracts to interfere with the bacterial mutagenesis assay used by us. Some urine components have been reported to inhibit the in vitro metabolizing system (Wendt et al., 1987) , like some complex environmental mixtures . Moreover, urine extracts are often toxic when assayed by the Ames test, especially if large amounts are involved (Heussner et al., 1985) . In our study, we often found considerable dispersion of urinary mutagenic activity values within the same exposure group, which accounts for the high variability of the urinary mutagenesis test. This is mainly due to the many passages the method requires and to the toxicity of urine extracts. Furthermore, histidine and/or unknown mutagen contents of Statistical companson with least exposed subgroup using the chi-square or Mann-Whitney test: "On TA98 + S9 + fi-glucuronida.se. 'Producing at least double number of spontaneous revertants. c Smoked during sampling day. *P < 0.05, "*P < 0.01. urinary extracts may increase the number of spontaneous revertants (false values or mutagenic activity of unknown origin).
Generally, the values of nicotine plus metabolites in urine from smokers are 2-18 times higher than the values of cotinine, which accounts on average for only -15% of nicotine metabolites in urine (Barlow et al., 1987) . The most representative metabolite of nicotine in urine (35%) has been identified M.Granella et al. as rran5-3'-hydroxycotinine (Byrd et al, 1992) , while free nicotine accounts for 10%. In our study, the levels of nicotine plus metabolites were related to recent exposure to tobacco smoke (number of cigarettes smoked during the sampling day).
The correlation between urinary mutagenic activity and cotinine levels was confirmed (Bartsch et al., 1990; Rahn et al., 1991) , but the levels of nicotine plus metabolites were better correlated to urinary mutagenicity than to cotinine. Cotinine is an indicator of mean tobacco smoke exposure in the days preceding sample collection, because its urinary excretion half-life is estimated to be 32.7 h or to fall within a range of 25-35 h, depending on the number of cigarettes smoked (Sepkovic et al, 1986; Benowitz and Jakob, 1993) . For the latter indicator, a worse correlation with urinary mutagenic activity than with nicotine plus metabolite levels was also found in one of our previous studies on smokers occupationally exposed to PAH (Clonfero et al, 1995) . The excretion kinetics of tobacco smoke mutagens are rapid (Kobayashi and Hayatsu, 1984) . In studies on volunteers, the peak of urinary mutagen activity appears 4-5 h after the first cigarette of the day. A return to basic values is observed 12-18 h after stopping smoking, with a urinary excretion half-life for mutagenic compounds of ~7 h (Kado et al, 1985) . A halflife of ~2 h is reported for nicotine (Benowitz and Jakob, 1993) . Other cotinine metabolites have longer half-lives, e.g. rrans-3'-hydroxycotinine has a urinary half-life of 5.9 h (Neurath et al, 1987) . The latter have been suggested as more reliable biomarkers of chronic exposure to tobacco smoke (Kyerematen et al, 1990) .
The metabolized mutagens which appear in smokers' urine are contained in the mainstream paniculate matter of tobacco smoke (Scherer et al, 1992) . They have rapid excretion kinetics, very similar to those of food, which are pyrolysates of proteins and/or polypeptides (Laser-Reutersward et al, 1987) , the metabolites of which appear in urine after ingestion of fried, grilled or barbecued meat (Baker et al, 1986; Sousa et al, 1985) . There is experimental evidence that primary aromatic amines are mainly implicated as urinary mutagens in smokers (Peluso et al, 1990) . Therefore, they too are very probably metabolites of the pyrolysis products of the protein compounds of tobacco, also occurring in tobacco surrogates (Menon and Bhide, 1984) . The absence of urinary mutagens in subjects who smoke unburned but only heated cigarettes and in snuff users has been demonstrated (Rahn et al, 1991) , although high quantities of nicotine and cotinine are found in the urine of such subjects (Curvall et al, 1987) . In the rat, too, administration of nicotine alone does not cause the appearance of urinary mutagens (Doolittle et al, 1991) .
Because of the different urinary half-life of cotinine with respect to tobacco smoke mutagens, in our study the correlation of cotinine with urinary mutagenicity was found to the poor.
However, when a large number of subjects were examined, some relationships between nicotine and/or cotinine with mutagens in urine (Bartsch et al, 1990; Rahn et al, 1991) or with the number of cigarettes usually smoked per day were found (Mohtashamipur et al, 1985; Kawano et al, 1987; La Voie et al, 1986; Tuomisto et al, 1986) . Some studies (Jaffe et al, 1983; Tuomisto et al, 1986) , like ours, have reported that urinary mutagenic activity does not depend on machine smoking-derived deliveries of tar; others have reported the opposite (Kriebel et al, 1983 ). There does not appear to be any relation between the type of curing (air-or flue-cured) and urinary mutagenic activity (Bartsch et al, 1990) . In our study, the highly variable mutagenic activity of smokers' urine did not turn out to be linked to the different machine-smoking derived deliveries of tar, demonstrating the important role in the absorption of genotoxic smoke components played by the various types of smoking behaviour adopted by individuals, including the frequency and volume of puffs, inhaling patterns and smoke retention time, which cannot be assessed through questionnaires (Vogt et al, 1979) . Low-delivery cigarette smokers have total puff volumes almost double those of medium-delivery cigarette smokers and serum cotinine levels much higher than would be expected by the smoking machine yields (Kolonen et al, 1988) . Nonetheless, a nicotine intake lower by 32% in low-tar in comparison to medium-tar smokers is reported (Rawbone, 1984) .
The use of biomarkers indicating cigarette smoke intake are therefore essential in studies aiming at evaluating urinary mutagenic activity. While urinary cotinine is a good marker for assessing chronic active exposure to tobacco smoke, in our opinion, quantitative measurement of nicotine plus metabolites in urine is a more reliable risk indicator for evaluation of bladder epithelium exposure to genotoxic agents due to tobacco smoke. Lastly, smoking workers exposed to other mutagenic agents should be monitored for occupationally caused urinary mutagenicity, controlling at least partially by the levels of nicotine plus metabolites in their urine the presence of genotoxic compounds due to smoking habits.
